Export 692 results:
Author Title [ Type(Asc)] Year
Filters: Keyword is Humans  [Clear All Filters]
Journal Article
J. Hirt, Ballhausen, N., Hering, A., Kliegel, M., Beer, T., and Meyer, G., Social Robot Interventions for People with Dementia: A Systematic Review on Effects and Quality of Reporting., J Alzheimers Dis, vol. 79, no. 2, pp. 773-792, 2021.
M. Bertoux, de Souza, L. Cruz, O'Callaghan, C., Greve, A., Sarazin, M., Dubois, B., and Hornberger, M., Social Cognition Deficits: The Key to Discriminate Behavioral Variant Frontotemporal Dementia from Alzheimer's Disease Regardless of Amnesia?, J Alzheimers Dis, vol. 49, no. 4, pp. 1065-74, 2016.
M. Wei, Zhao, B., Huo, K., Deng, Y., Shang, S., Liu, J., Li, Y., Ma, L., Jiang, Y., Dang, L., Chen, C., Wei, S., Zhang, J., Yang, H., Gao, F., and Qu, Q., Sleep Deprivation Induced Plasma Amyloid-β Transport Disturbance in Healthy Young Adults., J Alzheimers Dis, vol. 57, no. 3, pp. 899-906, 2017.
V. Delic, Ratliff, W. A., and Citron, B. A., Sleep Deprivation, a Link Between Post-Traumatic Stress Disorder and Alzheimer's Disease., J Alzheimers Dis, vol. 79, no. 4, pp. 1443-1449, 2021.
X. Yin, Jiang, X., Wang, J., Qian, S., Liu, F., and Qian, W., SIRT1 Deacetylates SC35 and Suppresses Its Function in Tau Exon 10 Inclusion., J Alzheimers Dis, vol. 61, no. 2, pp. 561-570, 2018.
S. C. McEwen, Siddarth, P., Abedelsater, B., Kim, Y., Mui, W., Wu, P., Emerson, N. D., Lee, J., Greenberg, S., Shelton, T., Kaiser, S., Small, G. W., and Merrill, D. A., Simultaneous Aerobic Exercise and Memory Training Program in Older Adults with Subjective Memory Impairments., J Alzheimers Dis, vol. 62, no. 2, pp. 795-806, 2018.
S. Hannonen, Andberg, S., Kärkkäinen, V., Rusanen, M., Lehtola, J. - M., Saari, T., Korhonen, V., Hokkanen, L., Hallikainen, M., Hänninen, T., Leinonen, V., Kaarniranta, K., Bednarik, R., and Koivisto, A. M., Shortening of Saccades as a Possible Easy-to-Use Biomarker to Detect Risk of Alzheimer's Disease., J Alzheimers Dis, vol. 88, no. 2, pp. 609-618, 2022.
Q. Ye, Bai, F., and Zhang, Z., Shared Genetic Risk Factors for Late-Life Depression and Alzheimer's Disease., J Alzheimers Dis, vol. 52, no. 1, pp. 1-15, 2016.
L. Gao, Cui, Z., Shen, L., and Ji, H. - F., Shared Genetic Etiology between Type 2 Diabetes and Alzheimer's Disease Identified by Bioinformatics Analysis., J Alzheimers Dis, vol. 50, no. 1, pp. 13-7, 2016.
E. E. Sundermann, Edmonds, E. C., Delano-Wood, L., Galasko, D. R., Salmon, D. P., Rubin, L. H., and Bondi, M. W., Sex Influences the Accuracy of Subjective Memory Complaint Reporting in Older Adults., J Alzheimers Dis, vol. 61, no. 3, pp. 1163-1178, 2018.
A. Sil, Erfani, A., Lamb, N., Copland, R., Riedel, G., and Platt, B., Sex Differences in Behavior and Molecular Pathology in the 5XFAD Model., J Alzheimers Dis, vol. 85, no. 2, pp. 755-778, 2022.
L. Rozzini, Lanfranchi, F., Pilotto, A., Catalani, S., Gilberti, M. Enrica, Paganelli, M., Apostoli, P., and Padovani, A., Serum Non-Ceruloplasmin Non-Albumin Copper Elevation in Mild Cognitive Impairment and Dementia due to Alzheimer's Disease: A Case Control Study., J Alzheimers Dis, vol. 61, no. 3, pp. 907-912, 2018.
R. Zanardini, Benussi, L., Fostinelli, S., Saraceno, C., Ciani, M., Borroni, B., Padovani, A., Binetti, G., and Ghidoni, R., Serum C-Peptide, Visfatin, Resistin, and Ghrelin are Altered in Sporadic and GRN-Associated Frontotemporal Lobar Degeneration., J Alzheimers Dis, vol. 61, no. 3, pp. 1053-1060, 2018.
I. Yasue, Matsunaga, S., Kishi, T., Fujita, K., and Iwata, N., Serotonin 2A Receptor Inverse Agonist as a Treatment for Parkinson's Disease Psychosis: A Systematic Review and Meta-analysis of Serotonin 2A Receptor Negative Modulators., J Alzheimers Dis, vol. 50, no. 3, pp. 733-40, 2016.
O. Elkana, Eisikovits, O. Reichman, Oren, N., Betzale, V., Giladi, N., and Ash, E. L., Sensitivity of Neuropsychological Tests to Identify Cognitive Decline in Highly Educated Elderly Individuals: 12 Months Follow up., J Alzheimers Dis, vol. 49, no. 3, pp. 607-16, 2016.
C. LoBue, Denney, D., Hynan, L. S., Rossetti, H. C., Lacritz, L. H., Hart, J., Womack, K. B., Woon, F. L., and C Cullum, M., Self-Reported Traumatic Brain Injury and Mild Cognitive Impairment: Increased Risk and Earlier Age of Diagnosis., J Alzheimers Dis, vol. 51, no. 3, pp. 727-36, 2016.
E. M. Arroyo-Anlló, Bouston, A. Turpin, Fargeau, M. - N., Baz, B. Orgaz, and Gil, R., Self-Consciousness in Patients with Behavioral Variant Frontotemporal Dementia., J Alzheimers Dis, vol. 49, no. 4, pp. 1021-9, 2016.
R. O'Caoimh, Timmons, S., and D Molloy, W., Screening for Mild Cognitive Impairment: Comparison of "MCI Specific" Screening Instruments., J Alzheimers Dis, vol. 51, no. 2, pp. 619-29, 2016.
S. Takenoshita, Terada, S., Yokota, O., Kutoku, Y., Wakutani, Y., Nakashima, M., Maki, Y., Hattori, H., and Yamada, N., Sally-Anne Test in Patients with Alzheimer's Disease Dementia., J Alzheimers Dis, vol. 61, no. 3, pp. 1029-1036, 2018.
X. Hua, Church, K., Walker, W., L'Hostis, P., Viardot, G., Danjou, P., Hendrix, S., and Moebius, H. J., Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Positive Modulator of HGF/MET, Fosgonimeton, in Healthy Volunteers and Subjects with Alzheimer's Disease: Randomized, Placebo-Controlled, Double-Blind, Phase I Clinical Trial., J Alzheimers Dis, vol. 86, no. 3, pp. 1399-1413, 2022.
M. Pejstrup Agger, Danielsen, E. Rubæk, Carstensen, M. Schultz, N Nguyen, M., Horning, M., Henney, M. Alexander, Jensen, C. Boe Ravn, Baandrup, A. Ohlhues, Kjær, T. Wesenberg, Madsen, K. Hougaard, Miskowiak, K., Petersen, P. Michael, and Høgh, P., Safety, Feasibility, and Potential Clinical Efficacy of 40 Hz Invisible Spectral Flicker versus Placebo in Patients with Mild-to-Moderate Alzheimer's Disease: A Randomized, Placebo-Controlled, Double-Blinded, Pilot Study., J Alzheimers Dis, vol. 92, no. 2, pp. 653-665, 2023.
J. Bennett, Burns, J., Welch, P., and Bothwell, R., Safety and Tolerability of R(+) Pramipexole in Mild-to-Moderate Alzheimer's Disease., J Alzheimers Dis, vol. 49, no. 4, pp. 1179-87, 2016.
E. Lacorte, Ancidoni, A., Zaccaria, V., Remoli, G., Tariciotti, L., Bellomo, G., Sciancalepore, F., Corbo, M., Lombardo, F. L., Bacigalupo, I., Canevelli, M., Piscopo, P., and Vanacore, N., Safety and Efficacy of Monoclonal Antibodies for Alzheimer's Disease: A Systematic Review and Meta-Analysis of Published and Unpublished Clinical Trials., J Alzheimers Dis, vol. 87, no. 1, pp. 101-129, 2022.
A. Shelef, Barak, Y., Berger, U., Paleacu, D., Tadger, S., Plopsky, I., and Baruch, Y., Safety and Efficacy of Medical Cannabis Oil for Behavioral and Psychological Symptoms of Dementia: An-Open Label, Add-On, Pilot Study., J Alzheimers Dis, vol. 51, no. 1, pp. 15-9, 2016.
X. - Y. He, Isaacs, C., and Yang, S. - Y., Roles of Mitochondrial 17β-Hydroxysteroid Dehydrogenase Type 10 in Alzheimer's Disease., J Alzheimers Dis, vol. 62, no. 2, pp. 665-673, 2018.